BioStock: Aqilion Takes Aim at Eosinophilic Esophagitis with AQ280
Eosinophilic esophagitis is a challenging chronic inflammatory condition. Often leading to painful swallowing and food impaction, which can be fatal, EoE represents a significant area of unmet medical need where effective treatments are lacking. Enter Aqilion, who have just completed a phase I study with their candidate AQ280. BioStock spoke with CEO Sarah Fredriksson to learn more about the candidate and its potential in EoE management.Read the interview with Sarah Fredriksson at biostock.se: Aqilion Takes Aim at Eosinophilic Esophagitis with AQ280 - BioStock